At a glance
ClinicalIndex Comparison RecordN/AActive· 802 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Identifying Opportunities for Prevention of Adverse Outcomes Following Female Genital
In Brief
An observational study for Female Genital Fistula and Incontinence. Active but no longer recruiting, targeting 802 participants across 1 site.
Detailed Summary
Following genital fistula repair, fistula repair breakdown and recurrence, persistent and incidence incontinence are major adverse outcomes, limiting women's health and wellbeing. Using a prospective design, the investigators seek to identify modifiable risk factors to establish key targets for intervention, followed by qualitative work to refine the feasibility and acceptability of potential intervention strategies.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsFemale Genital Fistula, Incontinence
CountriesUganda
Timeline
N/AActive
2023202420252026
Enrollment StartMay 2022
First PostedJun 2022
Primary CompletionMar 2026
TodayJul 2026
Study CompletionJul 2026
First PostedJun 29, 2022
Enrollment StartMay 20, 2022
Primary CompletionMar 31, 2026
Study CompletionJul 31, 2026
TodayJul 2, 2026
Enrollment to primary: 3.9 yearsPosted 4.0 years ago